To this purpose, the inflammatory status of COVID-19 positive and negative patients was evaluated, but surprisingly the canonical biomarkers in inflammation, such as WBC and C- C-reactive protein (CRP), display little if no difference between the two populations, with a slightly but not significative increase in COVID 19negative patients. The gene discussed is CRP; the disease is COVID-19.